查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1820225

脱髮治疗市场规模、份额、趋势及预测（按药物类型、适应症、性别、给药途径、配销通路和地区划分），2025 年至 2033 年

Alopecia Treatment Market Size, Share, Trends and Forecast by Drug Type, Indication, Gender, Route of Administration, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球脱髮治疗市场规模达34亿美元。展望未来， IMARC Group预测，到2033年，该市场规模将达到48亿美元，2025年至2033年的复合年增长率为3.9%。目前，北美占据市场主导地位，2024年的市占率将超过38.34%。脱髮盛行率的上升、医疗保健支出的巨额投入以及消费者日益增强的美学意识（强调外表和自我照顾的重要性），是推动市场发展的因素。

脱髮治疗市场正经历强劲增长，这得益于人们对脱髮问题的认识不断提高，以及医疗和美容解决方案的进步。由于老化、荷尔蒙失调、压力和自体免疫疾病等因素，脱髮盛行率不断上升，这显着增加了对有效治疗方案的需求。再生医学、干细胞疗法和先进药物等治疗方法的创新扩大了市场范围。此外，社群媒体影响力的不断增强和可支配收入的增加鼓励消费者寻求专业治疗，进一步推动了市场成长。此外，电子商务平台的扩张使得脱髮治疗更加便捷，尤其是在发展中地区，从而促进了市场的全球扩张。

在美国，脱髮治疗市场受到高度认知和对先进医疗解决方案强劲需求的推动。完善的医疗基础设施可支持创新疗法的开发和应用，例如口服和外用脱髮疗法。例如，2024年9月，美国製药公司Amplifica宣布其针对雄性秃的新型皮内注射疗法AMP-303的首次人体试验取得了令人欣喜的结果。研究表明，AMP-303在一次治疗后可显着增加头髮密度和厚度，且疗效持久，且安全性高。该市场还受益于对研发的大量投资，旨在探索新的头髮生长解决方案。此外，消费者对非侵入性和美容解决方案的日益青睐，以及专业皮肤科诊所的普及，使美国成为脱髮治疗的领先市场。此外，策略合作和产品发布也进一步巩固了其成长动能。

脱髮治疗市场趋势：

掉髮盛行率不断上升

雄性秃是一种常见的模式性脱髮，男性和女性均可发病。根据《美国皮肤病学会国际期刊》（JAAD）2023 年发表的一项调查，脱髮对不同种族和性别群体的影响不同，15% 的停经后女性和超过 50% 的老年男性会经历脱髮，而头髮稀疏最早可在青春期开始。此外，推动脱髮治疗市场发展的关键因素之一是遗传性脱髮以及斑秃等疾病的发生率不断上升。美国国家斑秃基金会估计，670 万美国人和全球约 1.6 亿人患有斑秃或可能患有斑秃。目前，美国约有 70 万人患有斑秃。此外，全球约有 2% 的人口患有斑秃，这凸显了这种导致脱髮的疾病的普遍性。根据脱髮治疗市场概况，随着越来越多的人意识到脱髮并寻求有效的治疗方案，该行业的需求正在增长。因此，随着医疗技术的进步和各种治疗方案的出现，人们开始寻求医疗援助来修復头髮，从而推动脱髮治疗市场大幅扩张。

医疗支出不断上涨

全球医疗支出的不断攀升是推动脱髮治疗市场成长轨蹟的关键因素。据报道，2020 年全球医疗支出平均成长了 21%。到 2021 年，这一数字进一步增长，比 2019 年高出惊人的 25%。此外，2021 年至 2022 年间，大多数同类国家的人均医疗支出都有所增加。据报道，美国、澳洲（2.4%）、加拿大（0.7%）和英国（0.5%）的人均医疗支出温和成长 2.9%。在有数资料的国家中，比利时的人均医疗支出增幅最大，2021 年至 2022 年间成长了 9.6%。值得注意的是，已开发国家的医疗支出成长尤为显着，显示人们愿意花钱购买尖端医疗服务，例如脱髮治疗。因此，不断增长的财务能力和增加的可支配收入使更多的人能够利用脱髮治疗方案，从而促进市场的成长。

美感意识的增强

此外，全球个人对外表和美学意识的日益重视，大大促进了脱髮治疗市场的扩张。国际毛髮修復外科学会 (ISHRS) 的一项调查显示，ISHRS 会员平均治疗了 165 名手术患者和 396 名非手术患者。此外，2021 年约有三分之二 (65%) 的 ISHRS 会员进行了 0-199 例毛髮修復手术，平均每位会员进行了 179 例，而 78% 的 ISHRS 会员进行了 0-19 例毛髮修復手术。 2021 年，会员平均每月完成 14 例毛髮修復手术。因此，这一上升的数字表明，人们对自身外表的自我意识不断增强，而社群媒体的影响和理想美丽标准的呈现加剧了这种意识。坚持感知的美学理想和文化压力导致对有效毛髮修復方案的需求显着增加。因此，随着越来越多的人寻求改善外观和解决脱髮问题的方法，脱髮治疗市场正在成长。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球脱髮治疗市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依药物类型

  • 米诺地尔
  • 非那雄胺
  • 其他的

第七章：市场区隔：依指标

  • 雄性秃
  • 斑秃
  • 全秃
  • 其他的

第八章：市场区隔：依性别

  • 男性
  • 女性

第九章：市场细分：依行政途径

  • 口服
  • 外用
  • 注射剂

第十章：市场区隔：按配销通路

  • 医院
  • 零售药局
  • 网路药局

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 12 章：SWOT 分析

第 13 章：价值链分析

第 14 章：波特五力分析

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aclaris Therapeutics Inc.
    • Cellmid Limited
    • Cipla Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • HCell Inc.
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Pfizer Inc.
    • Taisho Pharmaceutical Holdings Co. Ltd
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112025A4147

The global alopecia treatment market size was valued at USD 3.4 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.8 Billion by 2033, exhibiting a CAGR of 3.9% from 2025-2033. North America currently dominates the market, holding a market share of over 38.34% in 2024. The market is driven by the increasing prevalence of alopecia, significant investment in healthcare expenditure, and the growing aesthetic consciousness among consumers highlighting the importance of appearance and self-care.

The alopecia treatment market is experiencing robust growth, driven by rising awareness about hair loss conditions and advancements in medical and cosmetic solutions. Increasing prevalence of alopecia, fueled by factors such as aging, hormonal imbalances, stress, and autoimmune disorders, has significantly boosted demand for effective treatment options. Innovations in therapeutic approaches, including regenerative medicine, stem cell therapy, and advanced pharmaceuticals, have expanded the market's scope. Moreover, the growing influence of social media and increasing disposable income have encouraged consumers to seek professional treatments, further driving market growth. Additionally, the expansion of e-commerce platforms has made alopecia treatments more accessible, especially in developing regions, contributing to the market's global expansion.

In the United States, the alopecia treatment market is propelled by a high awareness level and strong demand for advanced medical solutions. A well-established healthcare infrastructure supports the development and adoption of innovative treatments, such as oral and topical therapies for alopecia. For instance, in September 2024, Amplifica, a U.S. based pharmaceutical company, announced promising results from its first-in-human trial of AMP-303, a novel intradermal treatment for androgenetic alopecia. The study showed AMP-303 significantly increased hair density and thickness after one treatment, with durable effects and a strong safety profile. The market also benefits from significant investments in research and development, aiming to discover novel solutions for hair regrowth. Moreover, rising consumer preference for non-invasive and aesthetic solutions, alongside the availability of specialized dermatology clinics, positions the U.S. as a leading market for alopecia treatments. Besides this, strategic collaborations and product launch further strengthen its growth trajectory.

Alopecia Treatment Market Trends:

Increasing Prevalence of Alopecia

Androgenetic alopecia is a prevalent form of patterned hair loss that is seen in men and women. As per the Journal of the American Academy of Dermatology International (JAAD) published survey in 2023, alopecia affects different racial and gender groups differently, 15% of postmenopausal women and over 50% of elderly males experience it, while thinning hair can begin as early as puberty. Apart from that, one of the crucial factors driving the development of the alopecia treatment market is the increasing incidence of alopecia, a hereditary condition, and disorders such as alopecia areata. The National Alopecia Areata Foundation estimates that 6.7 million Americans and about 160 million individuals worldwide have alopecia areata or may acquire it. Currently, alopecia areata affects about 700,000 persons in the United States. Furthermore, alopecia areata affects about 2% of people worldwide, underscoring the disorder's widespread prevalence that causes hair loss. As per the alopecia treatment market overview, demand in the industry is rising as more individuals become aware and look for efficient treatment solutions. Therefore, people are resorting to medical aid for hair restoration due to advances in medical technology and a wide range of treatment options accessible, leading to a considerable expansion in the market for alopecia therapy.

Rising Healthcare Expenditure

The escalating healthcare expenditure worldwide is a pivotal factor driving the growth trajectory of the alopecia treatment market. Global healthcare spending increased by 21% on average in 2020, as per reports. This number has increased even further by 2021, when it was a startling 25% higher than in 2019. Moreover, the per capita health spending increased in most peer countries between 2021 and 2022. A moderate 2.9% growth in per capita health spending was reported in the US, Australia (2.4%), Canada (0.7%), and the UK (0.5%). Among the countries for whom data was available, Belgium experienced the largest growth in per capita health spending, rising 9.6% between 2021 and 2022. Notably, developed nations show an especially notable increase in healthcare spending, indicating the willingness of individuals to spend money on cutting-edge medical treatments, such as alopecia treatments. Hence, the burgeoning financial capability and enhanced disposable income allow a larger section of the population to avail themselves of the alopecia treatment options, thus contributing to the growth of the market.

Growing Aesthetic Consciousness

Furthermore, the growing emphasis on physical appearance and aesthetic consciousness among individuals globally is significantly contributing to the expansion of the alopecia treatment market. A survey conducted by the International Society of Hair Restoration Surgery (ISHRS) revealed that ISHRS members treated on average 165 surgical patients and 396 non-surgical patients. Moreover, ISHRS members performed surgical procedures between 0-199 hair restoration in 2021 by around two-thirds (65%) of ISHRS members, with an average member performing 179 procedures, while 78% of ISHRS members performed 0-19 hair restoration surgical operations. Members completed an average of 14 hair restoration surgical procedures per month in 2021. As a result, this rising figure illustrates increased self-consciousness among individuals about their appearance, which is exacerbated by social media's effect and the representation of ideal beauty standards. The need to adhere to perceived aesthetic ideals and cultural pressures has resulted in a noteworthy demand for effective hair restoration options. Consequently, the market for alopecia treatments is growing as more people look for ways to improve their physical appearance and deal with their hair loss issues.

Alopecia Treatment Industry Segmentation:

Analysis by Drug Type:

  • Minoxidil
  • Finasteride
  • Others

Minoxidil is a commonly used medication that effectively treats alopecia in many forms. Minoxidil is a popular and easily accessible therapy option for male and female pattern hair loss. It is available over the counter in many locations. This FDA-approved drug comes in several forms, including foams and topical treatments. It slows down hair loss, stimulates hair growth, and increases blood supply to hair follicles. It is widely adopted due to its relative affordability when compared to prescription drugs and its efficacy in encouraging hair growth. For instance, as per a study by Research Gate, patients were treated with low-dose oral minoxidil (LDOM) for at least 3 months as a treatment for any type of alopecia, which offers a good safety profile to treat hair loss without any life-threatening adverse effects. Thus, the increasing number of alopecia is resulting in the adoption of minoxidil to treat alopecia, positively generating alopecia treatment market revenue.

Analysis by Indication:

  • Androgenic Alopecia
  • Alopecia Areata
  • Alopecia Totalis
  • Others

Androgenic alopecia leads the market with around 37.6% of market share in 2024. Androgenic alopecia, commonly known as male or female pattern baldness, holds the largest segment in the market. It is primarily due to the high prevalence of androgenic alopecia globally, which affects a significant portion of men and women. Additionally, the rising awareness and acceptance of treatment options, coupled with advances in therapeutic techniques such as topical treatments, oral medications, and hair transplant procedures, have further propelled the market growth. Hence key players are introducing advanced product variants to meet these needs. For instance, in February 2024, Pelage Pharmaceuticals, a clinical-stage regenerative medicine company created a novel treatment for hair loss, while announcing the completion of $16.75 million Series A fundraising. The funding will assist the development of a first-in-class treatment for androgenetic alopecia (pattern baldness) and other kinds of alopecia, including chemotherapy-induced hair loss. GV is leading the investment, which is also supported by Main Street Advisors, Visionary Ventures, and YK BioVentures. As a result, the increasing focus on aesthetic appearance and the psychological impact of hair loss has led to the rising demand for effective treatment solutions, solidifying androgenic alopecia's position in the alopecia treatment market outlook.

Analysis by Gender:

  • Male
  • Female

Female leads the market with around 59.8% of market share in 2024. The growing prevalence of alopecia in females coupled with a growing awareness and acceptance of medical treatments for hair loss are influencing the market growth. Women are seeking effective solutions for alopecia due to aesthetic concerns and the psychological impact of hair loss, leading to a significant demand for pharmaceutical and cosmetic treatments. Additionally, the expansion of product offerings specifically designed for female alopecia, including topical solutions, oral medications, and advanced therapies such as platelet-rich plasma (PRP) and low-level laser therapy (LLLT), has further propelled the growth of this segment. As per the American Academy of Dermatology (AAD) association, minoxidil is recognized as an over-the-counter medication approved by the US Food and Drug Administration (FDA) for treating female pattern hair loss (FPHL), since FPHL can be treated with medications that include 2% or 5% minoxidil. Therefore, the growing focus on female-centric marketing strategies and the rising trend of self-care and wellness among women are also contributing to the expansion of alopecia treatment market.

Analysis by Route of Administration:

  • Oral
  • Topical
  • Injectable

Topical segment holds the largest share, as it is widely used and accepted owing to its ease of use. Topical therapies, including minoxidil and corticosteroids, are non-invasive, can be administered directly to the afflicted area, and have fewer systemic adverse effects than oral and injectable options, and are frequently the first line of defense against hair loss. This route of administration is attributed to its popularity among patients who want quick fixes that work well without requiring physician care. According to the Cleveland Clinic, corticosteroids and other anti-inflammatory medications can be used to treat alopecia. It is rubbed topically (into the skin) as an ointment, cream, or foam, or injected into the scalp or other regions for the treatment.

Analysis by Distribution Channel:

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

Hospitals lead the market with around 40.3% of market share in 2024. Hospital dominance is attributed to the extensive infrastructure and specialized medical expertise available in hospital settings, which ensure comprehensive diagnosis and tailored treatment plans for alopecia patients. Hospitals often provide a range of therapeutic options, including prescription medications, advanced medical procedures, and supportive care, making them a preferred choice for individuals seeking professional and effective alopecia management. Moreover, hospitals frequently collaborate with leading pharmaceutical companies and research institutions to offer cutting-edge treatments. Hence, the trust and reliability associated with hospital care contribute to their leading position in the alopecia treatment market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 38.34%. The North America alopecia treatment market recent developments are marked by the robust healthcare infrastructure, increasing prevalence of alopecia, and increased awareness about available treatment options. The presence of major pharmaceutical companies and advancements in medical technology further bolster the market in this region. For instance, in June 2023, the U.S. Food and Drug Administration (FDA) announced the approval of ritlecitinib, a Janus kinase (JAK) inhibitor by Yale dermatologist Dr. Brett King, who worked with pharmaceutical company Pfizer for conducting a series of clinical trials with ritlecitinib. It is for the treatment of alopecia areata in adolescents and adults which is an oral medication under the name Litfulo. Furthermore, the growing inclination toward aesthetic procedures and a higher disposable income enable consumers to spend on treatments for hair loss, which is positively increasing the alopecia treatment demand in North America.

Key Regional Takeaways:

United States Alopecia Treatment Market Analysis

In 2024, United States accounted for 93.40% of the market share in North America. Alopecia treatment market in the United States is experiencing huge growth mainly because of heightened awareness about hair loss and a surge in demand for advanced treatments. Pharmaceutical therapies like oral Janus kinase (JAK) inhibitors are increasingly being sought after by people and prove the direction of advanced and effective solutions. This leaves a significant number of around 35 million males and 21 million females within the United States suffering from various forms of hair loss, resulting in an extensive patient population, as per reports. Consumer spending on personal care products also continues to drive the market; consumers increasingly search for remedies that can help improve their looks and make them feel better. At the forefront of the growth have been leading pharmaceutical companies, such as Pfizer and Eli Lilly, in their innovative treatments. Dermatologists play an important role in increasing access of patients to the treatments, but online platforms supplement the sources available to provide the patient with even more information about hair loss, thus increasing their availability.

Europe Alopecia Treatment Market Analysis

The alopecia treatment market in Europe is growing significantly, as people are becoming increasingly aware and there is a need for more effective treatments. The European Commission approved LITFULO (ritlecitinib) for the treatment of severe alopecia areata in patients aged 12 years or older in 2023, which was an important development for treatment options. Europe is also home to one of the highest prevalences of hair loss worldwide, with eight of the top ten countries for hair loss being in the region. The Czech Republic, in particular, boasts the highest prevalence of baldness, with more than 40% of adult men suffering from it, as per an industry report. Such a high incidence of alopecia contributes to a significant patient population, thereby further driving demand for advanced therapies. Pharmaceutical treatments are followed by a trend of increasing non-invasive treatments, like laser therapy and stem cell treatment. The concern of personal care and self-esteem among people is making them take these treatments, hence pushing the growth in the market even more.

Asia Pacific Alopecia Treatment Market Analysis

The Asia Pacific alopecia treatment market is growing rapidly, driven by increasing disposable incomes and a growing concern for appearance. In Japan, the prevalence of alopecia areata ranges between 1.45% and 2.18%, according to a study that highlights the significant emotional and social impacts of the condition. The study then determined the self-reported mood, self-esteem, and social interaction effects as 70.2%, 55.8%, and 48.9%, respectively. Such research reminds the importance of more effective treatments that can halt both the medical and psychological aspects of hair loss. Alopecia is increasingly becoming a problem in countries such as China, Japan, and India, and this is further increasing the demand for medical as well as cosmetic solutions. Non-invasive treatments, laser therapy, are becoming popular with market players investing more in R&D to introduce innovative, culturally tailored products. Moreover, hair clinics are multiplying and e-commerce solutions are accelerating the growth of the market.

Latin America Alopecia Treatment Market Analysis

The Latin American market for alopecia treatment is still growing, considering the growing consumers' awareness as well as an increasing availability of treatment options. A 2023 publication by Dermatol Ther (Heidelb) states that though often under-recognized, in many ways it can affect patients' quality of life. Latin America prevalence range for alopecia areata 0.2% to 3.8%. The prevalence in Mexico is estimated between 0.2% and 3.8%, whereas in Peru, it ranges between 0.1% and 0.2%. The prevalence in Colombia was reported at 0.05% in 2018, with the proportion being greater in women. This increasing awareness of the disease, coupled with a large population of patients, is driving up the demand for advanced treatments. The rising trend in cosmetic surgery along with the consumers' preference towards natural treatments are further boosting this market. In the region, leading companies are expanding their distribution networks to accommodate these evolving needs.

Middle East and Africa Alopecia Treatment Market Analysis

Alopecia treatment in the Middle East and Africa is increasingly done for medical and aesthetic reasons. However, no common consensus among the dermatologists on the prevalence of AA exists. For instance, according to a research article, the estimated prevalence of AA among the general population is believed to exceed 10% among more than one-third of dermatologists in Egypt, thereby providing a significant challenge to developing proper treatments. In Saudi Arabia, 42% of dermatologists estimated that the prevalence of AA was between 7-10%. The numbers above are reflective of the wide-reaching scope of alopecia, and as such, this trend is perpetually on the rise in the pharmaceuticals and non-invasive fields. Support for this market has also been increased by rising investments in healthcare, advanced technology in hair restoration, and rising emotions and social impacts of hair loss. More patients now seek key procedures there, such as hair transplants and laser treatments, in such places as South Africa and Egypt, to name only two.

Competitive Landscape:

The key players in the global market are actively engaged in several strategic initiatives to maintain their competitive edge. They are heavily investing in research and development to introduce innovative treatments and therapies that offer enhanced efficacy and fewer side effects. Additionally, these players are focusing on expanding their global presence by entering emerging markets and capitalizing on the growing demand for hair loss solutions. Collaborations and partnerships with dermatological clinics and healthcare providers are becoming increasingly common to ensure a wider distribution network. Moreover, several companies are leveraging digital marketing and e-commerce platforms to promote their products and reach a broader consumer base, emphasizing convenience and accessibility. For instance, in March 2023, Sun Pharma announced the successful acquisition of Concert Pharmaceuticals, Inc. Concert Pharmaceuticals is a late-stage clinical biopharmaceutical organization offering deuruxolitinib, an innovative deuterated oral JAK1/2 inhibitor, for the treatment of adult patients with moderate to severe alopecia areata.

The report provides a comprehensive analysis of the competitive landscape in the alopecia treatment market with detailed profiles of all major companies, including:

  • Aclaris Therapeutics Inc.
  • Cellmid Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • HCell Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Taisho Pharmaceutical Holdings Co. Ltd
  • Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the alopecia treatment market?
  • 2.What is the future outlook of the alopecia treatment market?
  • 3.What are the key factors driving the alopecia treatment market?
  • 4.Which region accounts for the largest alopecia treatment market share?
  • 5.Which are the leading companies in the global alopecia treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Alopecia Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Minoxidil
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Finasteride
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Androgenic Alopecia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Alopecia Areata
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Alopecia Totalis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Gender

  • 8.1 Male
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Female
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Oral
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Topical
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Retail Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Online Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Aclaris Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
    • 16.3.2 Cellmid Limited
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Cipla Limited
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Dr. Reddy's Laboratories Ltd.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 GlaxoSmithKline plc
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 HCell Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Johnson & Johnson
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Merck & Co. Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Pfizer Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Taisho Pharmaceutical Holdings Co. Ltd
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Teva Pharmaceutical Industries Ltd.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Alopecia Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Alopecia Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Alopecia Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Alopecia Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 5: Global: Alopecia Treatment Market: Breakup by Indication (in %), 2024
  • Figure 6: Global: Alopecia Treatment Market: Breakup by Gender (in %), 2024
  • Figure 7: Global: Alopecia Treatment Market: Breakup by Route of Administration (in %), 2024
  • Figure 8: Global: Alopecia Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 9: Global: Alopecia Treatment Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Alopecia Treatment (Minoxidil) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Alopecia Treatment (Minoxidil) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Alopecia Treatment (Finasteride) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Alopecia Treatment (Finasteride) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Alopecia Treatment (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Alopecia Treatment (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Alopecia Treatment (Androgenic Alopecia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Alopecia Treatment (Androgenic Alopecia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Alopecia Treatment (Alopecia Areata) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Alopecia Treatment (Alopecia Areata) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Alopecia Treatment (Alopecia Totalis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Alopecia Treatment (Alopecia Totalis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Alopecia Treatment (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Alopecia Treatment (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Alopecia Treatment (Male) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Alopecia Treatment (Male) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Alopecia Treatment (Female) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Alopecia Treatment (Female) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Alopecia Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Alopecia Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Alopecia Treatment (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Alopecia Treatment (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Alopecia Treatment (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Alopecia Treatment (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Alopecia Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Alopecia Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Alopecia Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Alopecia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Alopecia Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Alopecia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Alopecia Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Alopecia Treatment Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Alopecia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Alopecia Treatment Industry: SWOT Analysis
  • Figure 90: Global: Alopecia Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Alopecia Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Alopecia Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Alopecia Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 3: Global: Alopecia Treatment Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 4: Global: Alopecia Treatment Market Forecast: Breakup by Gender (in Million USD), 2025-2033
  • Table 5: Global: Alopecia Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 6: Global: Alopecia Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 7: Global: Alopecia Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Alopecia Treatment Market: Competitive Structure
  • Table 9: Global: Alopecia Treatment Market: Key Players